FAQ

Bath Cancer Research DiSC assay for CLL endorsed by US government panel

If you are a patient, please read.......
The median isn’t the message.

Click here if you have problems opening Request Form

Click here for a colourful resumé of the work of Bath Cancer Research (2.4MB)

Cliquez ici pour nos lecteurs Français qui désirent plus d'information

Service
Bath Cancer Research provides consultant haematologists/ oncologists an international service for the diseases above. Cells from their patients are tested for ex vivo drug response to a panel of cytotoxic drugs (up to 25 drugs). A report is sent to the physician to aid choice of optimum therapy. This information helps maximise the likelihood of response (and therefore survival) and reduces the risk of causing patient toxicity with no clinical benefit. Some assays are chargeable.

For those interested in assays for solid tumours or tests in the USA, please see link at http://www.weisenthal.org/.

Fully Accredited Service : we are pleased to announce that Bath Cancer Research is now a fully accredited laboratory registered with CPA (Clinical Pathology Accreditation).

Until further notice...... Bath Cancer Research has launched two far simpler, and therefore cheaper, drug sensitivity tests for CLL. These will allow physicians to test the main cytotoxic drugs of interest at diagnosis and also after the patients first regimen:

TRAC-0 for untreated CLL patients - testing five drugs at just £95.00 (Euros 150.00). Drugs tested fludarabine, cyclophosphamide, mitoxantrone, chlorambucil, methylprednisolone.

TRAC-1 for CLL patients at first relapse - testing 10 drugs and costing £195.00 (Euros 300.00).

Click here for further details.

Apart from any prior agreement, other NHS tests will cost £395.00 + to test the sensitivity to 20+ cytotoxic drugs.

FAQ resource

Click here for Request Form

For Patients click here

For Clinicians click here

Click here for a colourful resumé of the work of Bath Cancer Research (2.4MB)

Cliquez ici pour nos lecteurs Français qui désirent plus d'information.

Director: Dr Andrew G Bosanquet
BSc PhD MRCPath CChem FRSC

Wolfson Centre, Royal United Hospital, Bath, BA1 3NG, UK
Tel: +44 (0) 1225 824 124 ... Fax: +44 (0) 1225 824 114

Suggestions, comments and queries for Bath Cancer Research

© Bath Cancer Research 2000-2008

Date last modified: 26/3/08.

Webmaster: webmaster@caltri.org

[Home]